--- Connecting LPs & GPs worldwide
--- Connecting LPs & GPs worldwide
Toronto-based healthcare investor DRI Capital has closed Drug Royalty II with $701m in capital commitments. DRI, the fund’s manager, had a target of $500m for the vehicle, but said that it received greater interest than expected from investors, which came from the US, Canada, Europe, Australia and Asia.
In order to view premium content you need to be a Premium Subscriber. You can subscribe now to access premium online content.
Become a Premium SubscriberIf you are already a AltAssets subscriber please log in below.
